AirPocket goes live on iOS


Published 14-MAR-2017 16:45 P.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Having announced only last week that its AirPocket app facilitating money transfers to Latin America via Android devices had gone live, DigitalX informed the market on Tuesday that money transfers are now live on iOS via a free download on the App Store.

Furthermore, after the successful rollout of money transfers to Mexico and El Salvador last week, the same services are now being offered to Bolivia, the Dominican Republic and Honduras.

Although it is early stages in this roll-out, so investors considering this stock for their portfolio should seek professional financial advice.

These combined developments have effectively increased the group’s addressable market as the AirPocket app’s remittance service allows users to send money from the US to Latin American destinations for cash pickup or direct bank deposits. Users can also fund their money transfer by credit card, debit card or bank transfer.

Importantly, users can fund their remittances by prepaid debit card, a method which is increasingly used by under-banked individuals in lieu of costly cash agents. The low fees and applicable exchange rates offered by AirPocket deliver value that is particularly material to the immigrant community.

On this note, Chief Executive Leigh Travers said, “AirPocket offers steady foreign exchange premiums in response to dissatisfaction with the ‘casino-like’ experience remittance users face on competitor platforms, which offer Forex premiums that fluctuate significantly throughout the day and across the week”.

Travers also noted that the convenience of having an unchanging premium took a significant step out of remittance users’ calculation of the optimal sending platform.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free